Pfizer’s bladder cancer therapy meets main goal in late-stage study
Pfizer’s experimental treatment for a type of bladder cancer significantly improved the time that patients remained free of certain complications, including cancer recurrence, the drugmaker said on Friday following data from a late-stage study.